scholarly article | Q13442814 |
P50 | author | Anthony D Whetton | Q56421258 |
Tim C P Somervaille | Q73267757 | ||
Andrew Pierce | Q38641924 | ||
Richard Unwin | Q42908271 | ||
P2093 | author name string | Helen Smith | |
Stefan Meyer | |||
Axel Schambach | |||
Roberto Paredes | |||
Henri J van de Vrugt | |||
Andrew J K Williamson | |||
Harald Löffler | |||
Daniel J White | |||
Joanne Muter | |||
Marion Schneider | |||
Adam Stevens | |||
John A Chadwick | |||
Stella Pearson | |||
James R Kelly | |||
Simon Lovell | |||
Daniel H Wiseman | |||
Olga Kustikova | |||
Hsiang Ying Teng | |||
Kathleen Connors | |||
P2860 | cites work | High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. | Q54546717 |
Fanconi anemia (FA)-associated 3q gains in leukemic transformation consistently target EVI1, but do not affect low TERC expression in FA | Q57010929 | ||
Multiple Reaction Monitoring to Identify Sites of Protein Phosphorylation with High Sensitivity | Q57011006 | ||
The carboxyl domain of zinc fingers of the Evi-1 myeloid transforming gene binds a consensus sequence of GAAGATGAG | Q72420809 | ||
Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells | Q81353679 | ||
High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities | Q83822325 | ||
EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization | Q84583338 | ||
EVI1 expression in childhood acute lymphoblastic leukaemia is not restricted to MLL and BCR/ABL rearrangements and is influenced by age. | Q37555328 | ||
The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation | Q38348524 | ||
Prominent Oncogenic Roles of EVI1 in Breast Carcinoma | Q38716103 | ||
Activation of Evi1 inhibits cell cycle progression and differentiation of hematopoietic progenitor cells. | Q39232300 | ||
Ecotropic viral integration site 1, a novel oncogene in prostate cancer | Q39401617 | ||
Cytotoxic potency of H2O2 in cell cultures: impact of cell concentration and exposure time | Q39673341 | ||
EVI1 induces myelodysplastic syndrome in mice | Q39951095 | ||
Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. | Q39953712 | ||
Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia-derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption | Q40180071 | ||
The human promyelocytic leukemia zinc finger gene is regulated by the Evi-1 oncoprotein and a novel guanine-rich site binding protein | Q40708018 | ||
The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells | Q40722488 | ||
The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia | Q41213085 | ||
Developmental-stage-dependent transcriptional response to leukaemic oncogene expression. | Q42602670 | ||
Evi1 regulates Notch activation to induce zebrafish hematopoietic stem cell emergence. | Q42727640 | ||
Phosphorylation of the leukemic oncoprotein EVI1 on serine 196 modulates DNA binding, transcriptional repression and transforming ability | Q21133010 | ||
Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins | Q24291175 | ||
Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP | Q24302267 | ||
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage | Q24306743 | ||
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks | Q27864128 | ||
EVI1 promotes cell proliferation by interacting with BRG1 and blocking the repression of BRG1 on E2F1 activity | Q28209175 | ||
The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling | Q28213531 | ||
Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells | Q28288970 | ||
Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT | Q28296029 | ||
Ensembl 2017 | Q28584449 | ||
Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models of MLL-rearranged AML. | Q30823304 | ||
The transcription factor evi-1 is overexpressed, promotes proliferation, and is prognostically unfavorable in infratentorial ependymomas | Q33873238 | ||
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease | Q34094502 | ||
DNA damage regulates the mobility of Brca2 within the nucleoplasm of living cells. | Q34410989 | ||
Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies. | Q34536666 | ||
Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer. | Q34577891 | ||
A practical guide to evaluating colocalization in biological microscopy | Q34782140 | ||
The transcriptional corepressor CtBP: a foe of multiple tumor suppressors | Q35200291 | ||
Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity | Q35669072 | ||
Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors | Q35750824 | ||
Lentiviral gene transfer into human and murine hematopoietic stem cells: size matters | Q36053424 | ||
Cell of origin determines clinically relevant subtypes of MLL-rearranged AML | Q36409664 | ||
Four of the seven zinc fingers of the Evi-1 myeloid-transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/C)AAGATAA. | Q36690799 | ||
EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation | Q37068625 | ||
Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells | Q37163021 | ||
EVI1 splice variants modulate functional responses in ovarian cancer cells | Q37246860 | ||
BRCA2 diffuses as oligomeric clusters with RAD51 and changes mobility after DNA damage in live cells | Q43189526 | ||
EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia. | Q43486412 | ||
Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins. | Q45345900 | ||
Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis. | Q46456469 | ||
The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2 H-pyran-4-yl)-1,3-dihydro-2 H-imi | Q54114833 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 15 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 7662-7674 | |
P577 | publication date | 2018-09-01 | |
P1433 | published in | Nucleic Acids Research | Q135122 |
P1476 | title | EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 association | |
P478 | volume | 46 |
Q91906032 | C-terminal of E1A binding protein 1 enhances the migration of gastric epithelial cells and has a clinicopathologic significance in human gastric carcinoma |
Q89509869 | EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell Carcinoma |
Q100750044 | EVI1 phosphorylation at S436 regulates interactions with CtBP1 and DNMT3A and promotes self-renewal |
Search more.